As the medical community learns more about different cancers and how they spread, doctors try to determine the best time to begin screening patients. New evidence suggests one type of cancer is affecting a younger group than expected.

There's no doubt about it: preventative cancer screening can save lives. But new evidence suggests that some screenings may be inappropriate and even risky.

Doctors may now have another tool in their arsenal for the treatment of chronic lymphocytic leukemia (CLL).

False-positives are a potential downside of breast cancer screening, and one that the US Preventive Services Task Force (USPSTF) says patients and their doctors should consider.

The US Preventive Services Task Force (USPSTF) has now issued its final recommendations on breast cancer screening, including a discussion of the potential benefits and harms of mammography performed every two years.

Since the peak of cancer mortality in 1991, there have been countless advances in treatment and preventive health. And those advances may be starting to pay off.

Detecting cancer in surgery may have just gotten a whole lot easier.

Cancer patients have enough to worry about — they shouldn't have to worry about the health effects of medications taken before cancer surgery. And new evidence suggests they may not have to.

Doctors may now have a new — and equally effective — breast cancer screening tool in their arsenal.

Teaching an old drug a new trick may not be so far-fetched.